TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis.
about
Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.Nuclear features of infiltrating urothelial carcinoma are distinguished from low-grade noninvasive papillary urothelial carcinoma by image analysis.Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia.Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
P2860
TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
TP53 overexpression is an inde ...... astic syndromes with fibrosis.
@en
type
label
TP53 overexpression is an inde ...... astic syndromes with fibrosis.
@en
prefLabel
TP53 overexpression is an inde ...... astic syndromes with fibrosis.
@en
P2093
P2860
P356
P1476
TP53 overexpression is an inde ...... astic syndromes with fibrosis.
@en
P2093
Alyaa Al-Ibraheemi
Cameron C Yin
Carlos E Bueso-Ramos
Joseph D Khoury
L Jeffrey Medeiros
Mariko Yabe
Raja Luthra
Roberto N Miranda
Sanam Loghavi
P2860
P356
10.1111/BJH.13529
P407
P577
2015-06-30T00:00:00Z